Effect of cervical priming with misoprostol on cervical entry in women undergoing vaginoscopic hysteroscopy for evaluation of abnormal uterine bleeding: a randomized controlled trial

  • B. Nandhini
  • Dilip Kumar Maurya
  • Anish Keepanasseril
  • N. S. Kubera
General Gynecology
  • 15 Downloads

Abstract

Objective

To study the effect of cervical priming with misoprostol on cervical entry in women undergoing diagnostic hysteroscopy for evaluation of abnormal uterine bleeding.

Methods

Randomized controlled trial conducted in teaching hospital and tertiary referral center on 122 women requiring diagnostic hysteroscopy for evaluation of abnormal uterine bleeding. Women were randomized into two equal groups (n = 122). Study group received 200-μg vaginal misoprostol, 3 h prior to vaginoscopic hysteroscopy. No drug was used in control group. No analgesia or anesthesia was used in either group. Outcome measure included (i) ease of cervical entry (Likert scale), and (ii) pain scoring (Visual Analog Scale) and procedural entry time.

Results

Forty-six (75.41%) patients in the study group and 17 (27.87%) in control group had easy or very easy entry (Likert scale-4 and 5) (p < 0.001). Median pain scoring by VAS and the median procedural entry time was significantly lower in the study group compared to the control group (p < 0.001).

Conclusion

Use of 200-μg vaginal misoprostol, administered vaginally 3 h before diagnostic vaginoscopic hysteroscopy, was found to be simple and effective method of cervical priming in facilitating cervical entry with minimal side effects.

Clinical Trial registry of India (CTRI): (CTRI/2015/04/005666) (website: http://ctri.nic.in).

Keywords

Cervical priming Ease of cervical entry Misoprostol Vaginoscopic hysteroscopy 

Notes

Author contributions

DKM: involved in designing, writing the draft, and approved the final version. NB: involved in designing, collection, and revision of the manuscript. AK: designed the study, analysis, reviewed, revised, and approved the manuscript. NSK: involved in designing and revision of the manuscript.

Compliance with ethical standards

Conflict of interest

All authors declare no conflicts of interest.

Ethical approval

All procedures performed in this study were done with the ethical standards set by the Institute Scientific Advisory and Ethical committee (Human Studies), in accordance with the 1964 Helsinki declaration and its later amendments. Study was approved by the Institute Ethics Committee (Human Studies), JIPMER, Puducherry, India (JIP/IEC/2014/8/403).

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Birinyi L, Daragó P, Török P, Csiszár P, Major T, Borsos A et al (2004) Predictive value of hysteroscopic examination in intrauterine abnormalities. Eur J Obstet Gynecol Reprod Biol 115(1):75–79CrossRefPubMedGoogle Scholar
  2. 2.
    Bettocchi S, Ceci O, Nappi L, Di Venere R, Masciopinto V, Pansini V et al (2004) Operative office hysteroscopy without anesthesia: analysis of 4863 cases performed with mechanical instruments. J Am Assoc Gynecol Laparosc 11(1):59–61CrossRefPubMedGoogle Scholar
  3. 3.
    Cooper NA, Khan KS, Clark TJ (2010) Local anaesthesia for pain control during outpatient hysteroscopy: systematic review and meta-analysis. BMJ 23(340):c1130.  https://doi.org/10.1136/bmj.c1130 CrossRefGoogle Scholar
  4. 4.
    Vercellini P, Colombo A, Mauro F, Oldani S, Bramante T, Crosignani PG (1994) Paracervical anesthesia for outpatient hysteroscopy. Fertil Steril 62(5):1083–1085CrossRefPubMedGoogle Scholar
  5. 5.
    El-Mazny A, Abou-Salem N (2011) A double-blind randomized controlled trial of vaginal misoprostol for cervical priming before outpatient hysteroscopy. Fertil Steril 96(4):962–965CrossRefPubMedGoogle Scholar
  6. 6.
    Bettocchi S, Selvaggi L (1997) A vaginoscopic approach to reduce the pain of office hysteroscopy. J Am Assoc Gynecol Laparosc 4(2):255–258CrossRefPubMedGoogle Scholar
  7. 7.
    Likert R (1932) A technique for the measurement of attitudes. Arch Psychol 140:1–55Google Scholar
  8. 8.
    Huskisson EC (1974) Measurement of pain. Lancet 2(7889):1127–1131CrossRefPubMedGoogle Scholar
  9. 9.
    Tasma ML, Louwerse MD, Hehenkamp WJ, Geomini PM, Bongers MY, Veersema S et al (2018) Misoprostol for cervical priming prior to hysteroscopy in postmenopausal and premenopausal nulliparous women; a multicentre randomised placebo controlled trial. BJOG 125(1):81–89CrossRefPubMedGoogle Scholar
  10. 10.
    Batukan C, Ozgun MT, Ozcelik B, Aygen E, Sahin Y, Turkyilmaz C (2008) Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, double-blind, placebo-controlled comparison of vaginal and oral misoprostol. Fertil Steril 89(4):966–973CrossRefPubMedGoogle Scholar
  11. 11.
    Sordia-Hernández LH, Rosales-Tristan E, Vazquez-Mendez J, Merino M, Iglesias JL, Garza-Leal JG et al (2011) Effectiveness of misoprostol for office hysteroscopy without anesthesia in infertile patients. Fertil Steril 95(2):759–761CrossRefPubMedGoogle Scholar
  12. 12.
    Nada AM, Elzayat AR, Awad MH, Metwally AA, Taher AM, Ogila AI et al (2016) Cervical priming by vaginal or oral misoprostol before operative hysteroscopy: a double-blind, randomized controlled trial. J Minim Invasive Gynecol 23(7):1107–1112CrossRefPubMedGoogle Scholar
  13. 13.
    Ganer Herman H, Kerner R, Gluck O, Feit H, Keidar R, Bar J et al (2017) Different routes of misoprostol for same-day cervical priming prior to operative hysteroscopy: a randomized blinded trial. J Minim Invasive Gynecol 24(3):455–460CrossRefPubMedGoogle Scholar
  14. 14.
    Fouda UM, Gad Allah SH, Elshaer HS (2016) Optimal timing of misoprostol administration in nulliparous women undergoing office hysteroscopy: a randomized double-blind placebo-controlled study. Fertil Steril 106(1):196–201CrossRefPubMedGoogle Scholar
  15. 15.
    Kesrouani A, Maalouf S, Mansour F, Attieh E (2016) Use of oral misoprostol for cervical priming before hysteroscopy: a randomized comparison of two dosages. Gynecol Obstet Invest 81(4):333–338CrossRefPubMedGoogle Scholar
  16. 16.
    Singh N, Ghosh B, Naha M, Mittal S (2009) Vaginal misoprostol for cervical priming prior to diagnostic hysteroscopy–efficacy, safety and patient satisfaction: a randomized controlled trial. Arch Gynecol Obstet 279(1):37–40CrossRefPubMedGoogle Scholar
  17. 17.
    Valente EP, de Amorim MMR, Costa AAR, de Miranda DV (2008) Vaginal misoprostol prior to diagnostic hysteroscopy in patients of reproductive age: a randomized clinical trial. J Minim Invasive Gynecol 15(4):452–458CrossRefPubMedGoogle Scholar
  18. 18.
    Cooper NA, Smith P, Khan KS, Clark TJ (2011) Does cervical preparation before outpatient hysteroscopy reduce women’s pain experience? A systematic review. BJOG 118(11):1292–1301CrossRefPubMedGoogle Scholar
  19. 19.
    Hassa H, Aydin Y, Oge T, Cicek K (2013) Effectiveness of vaginal misoprostol and rectal nonsteroidal anti-inflammatory drug in vaginoscopic diagnostic outpatient hysteroscopy in primarily infertile women: double-blind, randomized, controlled trial. J Minim Invasive Gynecol 20(6):880–885CrossRefPubMedGoogle Scholar
  20. 20.
    Fouda UM, Elsetohy KA, Elshaer HS, Hammad BEM, Shaban MM, Youssef MA et al (2017) Misoprostol prior to diagnostic office hysteroscopy in the subgroup of patients with no risk factors for cervical stenosis: a randomized double blind placebo-controlled trial. Gynecol Obstet Invest.  https://doi.org/10.1159/000480234 PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • B. Nandhini
    • 1
  • Dilip Kumar Maurya
    • 1
  • Anish Keepanasseril
    • 1
  • N. S. Kubera
    • 1
  1. 1.Department of Obstetrics and GynecologyJawaharlal Institute of Post-graduate Medical Education and Research (JIPMER)PondicherryIndia

Personalised recommendations